Venkatesan Jay
Insider CIK 1413350 · ONTY EVP and General Manager · LBIO Director, 10% owner · ELTX See Remarks, Director · ALPN President, Director, 10% owner · XCUR Director · SER Director · ACCP 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2026-08-31 | 2026-09-02 | 21,750 | — | $0 | 21,750 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2026-08-31 | 2026-09-02 | 21,750 | — | $0 | 21,750 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 15,250 | — | $0 | 15,250 | SEC↗ |
| SER Serina Therapeutics, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 96,525 | $2.25 | $217.2K | 0 | SEC↗ |
| SER Serina Therapeutics, Inc. | C Conversion | 2026-06-17 | 2026-06-22 | 224,152 | $2.25 | $504.3K | 231,705 | SEC↗ |
| SER Serina Therapeutics, Inc. | P Buy | 2026-05-22 | 2026-06-22 | 589 | $1.78 | $1.0K | 589 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award | 2026-03-31 | 2026-04-21 | 7,553 | $1.94 | $14.7K | 7,553 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award deriv | 2025-11-07 | 2025-11-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2025-05-19 | 2025-05-20 | 7,900 | — | $0 | 7,900 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award deriv | 2025-04-08 | 2025-04-10 | 96,525 | $5.18 | $500.0K | 96,525 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award deriv | 2025-02-12 | 2025-02-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | X Exercise deriv | 2024-11-26 | 2024-11-29 | 50,000 | — | $0 | 0 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | X Exercise | 2024-11-26 | 2024-11-29 | 50,000 | $0.01 | $500 | 179,581 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2024-11-21 | 2024-11-25 | 4,100 | — | $0 | 4,100 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | P Buy deriv | 2024-06-28 | 2025-01-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | P Buy deriv | 2024-06-28 | 2025-01-02 | 50,000 | $4.99 | $249.5K | 50,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | P Buy deriv | 2024-06-28 | 2024-07-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | P Buy deriv | 2024-06-28 | 2024-07-02 | 50,000 | $4.99 | $249.5K | 50,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | P Buy deriv | 2024-06-28 | 2024-07-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | P Buy deriv | 2024-06-28 | 2024-07-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | P Buy deriv | 2024-06-28 | 2024-07-02 | 50,000 | $4.99 | $249.5K | 50,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | P Buy deriv | 2024-06-28 | 2024-07-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | P Buy deriv | 2024-06-28 | 2024-07-02 | 50,000 | $4.99 | $249.5K | 50,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | P Buy deriv | 2024-06-28 | 2024-07-02 | 50,000 | $4.99 | $249.5K | 50,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2023-12-28 | 2023-12-29 | 4,100 | — | $0 | 4,100 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | M Exercise deriv | 2022-07-15 | 2022-07-19 | 20,063 | $0.45 | $9.0K | 70,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | M Exercise | 2022-07-15 | 2022-07-19 | 20,063 | $0.45 | $9.0K | 238,126 | SEC↗ |
| ANGN Angion Biomedica Corp. | P Buy | 2022-05-25 | 2022-05-27 | 11,313 | $1.25 | $14.1K | 1,891,947 | SEC↗ |
| ANGN Angion Biomedica Corp. | P Buy | 2022-05-24 | 2022-05-25 | 32,200 | $1.24 | $39.9K | 1,721,457 | SEC↗ |
| ANGN Angion Biomedica Corp. | P Buy | 2022-05-20 | 2022-05-25 | 50,000 | $1.23 | $61.5K | 1,689,257 | SEC↗ |
| ANGN Angion Biomedica Corp. | A Award deriv | 2022-03-03 | 2022-03-04 | 600,000 | — | $0 | 600,000 | SEC↗ |
| ANGN Angion Biomedica Corp. | A Award deriv | 2022-03-03 | 2022-03-04 | 160,000 | — | $0 | 760,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ANGN Angion Biomedica Corp. | P Buy | 2021-12-28 | 2021-12-29 | 210,337 | $2.66 | $559.5K | 1,639,257 | SEC↗ |
| ANGN Angion Biomedica Corp. | P Buy | 2021-12-27 | 2021-12-29 | 66,907 | $2.55 | $170.6K | 1,428,920 | SEC↗ |
| ANGN Angion Biomedica Corp. | P Buy | 2021-12-20 | 2021-12-22 | 3,527 | $2.54 | $9.0K | 1,362,013 | SEC↗ |
| ANGN Angion Biomedica Corp. | P Buy | 2021-12-17 | 2021-12-20 | 13,742 | $2.54 | $34.9K | 1,358,486 | SEC↗ |
| ANGN Angion Biomedica Corp. | P Buy | 2021-12-16 | 2021-12-20 | 27,883 | $2.55 | $71.1K | 1,344,744 | SEC↗ |
| ANGN Angion Biomedica Corp. | P Buy | 2021-12-15 | 2021-12-17 | 77,604 | $2.41 | $187.0K | 1,316,861 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2021-09-17 | 2021-09-21 | 400,000 | $9.40 | $3.76M | 2,600,980 | SEC↗ |
| ANGN Angion Biomedica Corp. | F Tax w/h | 2021-06-24 | 2021-12-17 | 41,091 | $13.78 | $566.2K | 1,239,257 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | M Exercise deriv | 2021-03-31 | 2021-04-23 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | M Exercise | 2021-03-31 | 2021-04-23 | 7,650 | $3.62 | $27.7K | 218,063 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | M Exercise deriv | 2021-03-30 | 2021-04-23 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | M Exercise | 2021-03-30 | 2021-04-23 | 7,650 | $4.09 | $31.3K | 210,413 | SEC↗ |
| ANGN Angion Biomedica Corp. | X Exercise deriv | 2021-02-09 | 2022-05-27 | 396,329 | — | $0 | 0 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion | 2021-02-09 | 2022-05-27 | 262 | $11.57 | $3.0K | 1,439,525 | SEC↗ |
| ANGN Angion Biomedica Corp. | S Sale | 2021-02-09 | 2022-05-27 | 159,177 | $16.00 | $2.55M | 1,367,263 | SEC↗ |
| ANGN Angion Biomedica Corp. | X Exercise | 2021-02-09 | 2022-05-27 | 396,329 | $6.43 | $2.55M | 1,598,440 | SEC↗ |
| ANGN Angion Biomedica Corp. | X Exercise deriv | 2021-02-09 | 2021-02-11 | 237,152 | — | $0 | 0 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion deriv | 2021-02-09 | 2021-02-11 | 1,804 | — | $0 | 0 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion deriv | 2021-02-09 | 2021-02-11 | 0 | — | $0 | 0 | SEC↗ |
| ANGN Angion Biomedica Corp. | F Tax w/h | 2021-02-09 | 2021-02-11 | 31,966 | $16.00 | $511.5K | 1,037,017 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion | 2021-02-09 | 2021-02-11 | 165,094 | — | $0 | 1,202,111 | SEC↗ |
| ANGN Angion Biomedica Corp. | X Exercise | 2021-02-09 | 2021-02-11 | 237,152 | $6.43 | $1.52M | 1,439,263 | SEC↗ |
| ANGN Angion Biomedica Corp. | S Sale | 2021-02-09 | 2021-02-11 | 159,177 | $16.00 | $2.55M | 1,208,086 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion | 2021-02-09 | 2021-02-11 | 262 | $11.57 | $3.0K | 1,280,348 | SEC↗ |
| ANGN Angion Biomedica Corp. | A Award deriv | 2021-02-04 | 2021-02-08 | 178,920 | — | $0 | 178,920 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2021-01-04 | 2021-01-05 | 7,650 | — | $0 | 7,650 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | J Other | 2020-12-22 | 2020-12-22 | 993,801 | — | $0 | 3,000,980 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | J Other | 2020-12-22 | 2020-12-22 | 181,024 | — | $0 | 202,763 | SEC↗ |
| XCUR EXICURE, INC. | M Exercise deriv | 2020-07-06 | 2020-07-08 | 9,310 | — | $0 | 0 | SEC↗ |
| XCUR EXICURE, INC. | M Exercise deriv | 2020-07-06 | 2020-07-08 | 12,930 | — | $0 | 0 | SEC↗ |
| XCUR EXICURE, INC. | M Exercise | 2020-07-06 | 2020-07-08 | 9,310 | $0.65 | $6.1K | 311,544 | SEC↗ |
| XCUR EXICURE, INC. | M Exercise | 2020-07-06 | 2020-07-08 | 12,930 | $1.03 | $13.3K | 324,473 | SEC↗ |
| XCUR EXICURE, INC. | A Award deriv | 2020-06-04 | 2020-06-08 | 21,693 | — | $0 | 21,693 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2020-01-02 | 2020-01-06 | 7,650 | — | $0 | 7,650 | SEC↗ |
| XCUR EXICURE, INC. | P Buy | 2019-08-02 | 2019-08-06 | 250,000 | $2.00 | $500.0K | 302,234 | SEC↗ |
| XCUR EXICURE, INC. | A Award deriv | 2019-06-14 | 2019-06-14 | 21,693 | — | $0 | 21,693 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy deriv | 2019-01-18 | 2019-01-22 | 74,441 | — | $0 | 74,441 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2019-01-18 | 2019-01-22 | 190,875 | $5.37 | $1.02M | 3,994,781 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2019-01-02 | 2019-01-04 | 7,650 | — | $0 | 7,650 | SEC↗ |
| XCUR EXICURE, INC. | A Award deriv | 2018-06-19 | 2018-06-21 | 21,693 | — | $0 | 21,693 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2018-01-02 | 2018-01-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XCUR Max-1 Acquisition Corp | A Award deriv | 2017-09-26 | 2017-09-28 | 12,929 | — | $0 | 12,929 | SEC↗ |
| XCUR Max-1 Acquisition Corp | A Award deriv | 2017-09-26 | 2017-09-28 | 24,824 | — | $0 | 24,824 | SEC↗ |
| XCUR Max-1 Acquisition Corp | A Award deriv | 2017-09-26 | 2017-09-28 | 9,309 | — | $0 | 9,309 | SEC↗ |
| XCUR Max-1 Acquisition Corp | J Other | 2017-09-26 | 2017-09-28 | 90,192 | — | $0 | 90,192 | SEC↗ |
| XCUR Max-1 Acquisition Corp | A Award | 2017-09-26 | 2017-09-28 | 52,234 | — | $0 | 52,234 | SEC↗ |
| XCUR Max-1 Acquisition Corp | P Buy | 2017-09-26 | 2017-09-28 | 66,666 | $3.00 | $200.0K | 156,858 | SEC↗ |
| XCUR Max-1 Acquisition Corp | J Other | 2017-09-26 | 2017-09-28 | 190,957 | — | $0 | 190,957 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2017-07-24 | 2017-07-26 | 90,063 | — | $0 | 90,063 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | J Other | 2017-07-24 | 2017-07-26 | 18,633 | — | $0 | 18,633 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award | 2017-07-24 | 2017-07-26 | 21,739 | — | $0 | 21,739 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | J Other | 2017-07-24 | 2017-07-26 | 3,803,906 | — | $0 | 3,803,906 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | J Other | 2017-07-24 | 2017-07-26 | 18,633 | — | $0 | 18,633 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2017-06-01 | 2017-06-05 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2016-08-16 | 2016-08-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2015-06-12 | 2015-06-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2014-12-16 | 2014-12-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2014-12-05 | 2014-12-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award | 2014-09-23 | 2014-09-25 | 250,000 | $2.00 | $500.0K | 250,000 | SEC↗ |
| ONTY Oncothyreon Inc. | P Buy | 2014-09-23 | 2014-09-26 | 250,000 | $2.00 | $500.0K | 250,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2014-09-04 | 2014-09-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award | 2014-08-08 | 2014-08-12 | 3,776,723 | — | $0 | 3,826,723 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award | 2014-08-08 | 2014-08-12 | 263,493 | — | $0 | 263,493 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2013-11-18 | 2014-03-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ACCP ACCESS PHARMACEUTICALS INC | S Sale | 2012-06-29 | 2012-06-29 | 179,157 | $0.55 | $98.5K | 2,413,163 | SEC↗ |
| ACCP ACCESS PHARMACEUTICALS INC | S Sale | 2012-06-28 | 2012-06-29 | 25,000 | $0.68 | $17.0K | 2,592,320 | SEC↗ |
| ACCP ACCESS PHARMACEUTICALS INC | S Sale | 2012-05-16 | 2012-05-16 | 140,300 | $0.67 | $94.0K | 2,617,320 | SEC↗ |
| ACCP ACCESS PHARMACEUTICALS INC | S Sale | 2012-05-15 | 2012-05-16 | 1,000 | $0.85 | $850 | 2,757,620 | SEC↗ |